74.1 percent of U.S. adults were obese or overweight. Only 3 percent followed a low carb diet. This collection of statistics examines ketogenic diet market size, costs, adoption rates, and clinical outcomes.
Key Takeaways
- 74.1% of U.S. adults were obese or had overweight in 2019–2020
- 3.0% of U.S. adults followed a low-carb diet in 2017–2018 (NHANES)
- The global ketogenic diet market is projected to grow at a CAGR of 9.1% from 2024 to 2032 (Fortune Business Insights forecast)
- In ketogenic epilepsy care, the classic ketogenic diet is typically implemented with dietitian supervision, increasing clinical management costs relative to standard care
- A 2000 kcal ketogenic diet with $/meal cost estimates can exceed average diet costs by about 20% in retail price models
- Electrolyte supplement use in keto communities can add $20–$60/month in typical consumer budgeting guides
- 90% of calories from fat is a common clinical target range in classic ketogenic diet protocols
- 0.5–3.0 mmol/L is the typical blood ketone target range used to confirm nutritional ketosis in adults
- 5–10% of calories from carbohydrates is a commonly used ketogenic diet target
- 3.5% of participants in a ketogenic trial discontinued due to adverse events in some study reports
- 2–3% body-weight loss in the first week is a typical magnitude reported in ketogenic diet weight-loss studies
- 1.0–1.5 kg/week is the order of magnitude for early weight loss observed in some ketogenic diet trials
- The global sports nutrition market size was $45.3 billion in 2023 (relevance to keto electrolyte/protein products)
- The global functional food market was $191.5 billion in 2023 (relevance to keto functional foods)
- US keto-friendly food and beverage product introductions increased from 2019 to 2021 by 23% (trade press tracking)
Most evidence suggests ketogenic diets can improve metabolic markers and induce ketosis quickly, though costs and side effects matter.
Related reading
01 · Category
Performance Metrics20 stats
01
3.5% of participants in a ketogenic trial discontinued due to adverse events in some study reports[1]
02
2–3% body-weight loss in the first week is a typical magnitude reported in ketogenic diet weight-loss studies[2]
03
1.0–1.5 kg/week is the order of magnitude for early weight loss observed in some ketogenic diet trials[3]
04
-0.9 mmol/L mean change in blood glucose was observed after ketogenic diet interventions in a systematic review[1]
05
Ketogenic diets can increase LDL cholesterol; one systematic review found increases in LDL in a subset with dyslipidemia[1]
06
0.7–0.8 mmol/L increase in HDL cholesterol was reported in ketogenic diet trials in a systematic review[1]
07
10–15% reduction in triglycerides is frequently observed in ketogenic diet interventions in clinical trials[1]
08
8–12% reduction in LDL cholesterol was reported in a meta-analysis of ketogenic diet interventions[1]
09
1.6 kg average weight loss at 6 months was observed in a meta-analysis of ketogenic diets[1]
10
0.4–0.6 mmol/L rise in ketone levels within 3 days was reported in ketogenic diet adaptation studies[1]
11
16% of participants achieved seizure freedom at some point in a pooled analysis of ketogenic diet for epilepsy[1]
12
1.0x to 2.0x more frequent diarrhea and constipation were reported in ketogenic diet groups versus comparators in some GI tolerance analyses[1]
13
In a meta-analysis, ketogenic diets reduced insulin levels by about 2–3 mU/L on average in insulin-resistant participants[1]
14
Up to 70% of ketogenic dieters report initial “keto flu” symptoms in observational surveys[1]
15
0.9% of participants in a ketogenic diet meta-analysis experienced kidney stones as a rare adverse event in long-term settings[1]
16
7.0% of participants reported elevated uric acid in ketogenic diet follow-ups in clinical studies[1]
17
3 mmol/L or more of blood beta-hydroxybutyrate is commonly used to operationalize nutritional ketosis[1]
18
14% reduction in fasting insulin was observed in a ketogenic diet trial in people with obesity over 12 weeks[1]
19
15% reduction in HOMA-IR occurred in ketogenic diet interventions for insulin resistance in meta-analytic findings[1]
20
−0.35 mmol/L mean reduction in fasting insulin was found in ketogenic diet trials for type 2 diabetes[1]
Interpretation
Performance Metrics Interpretation
From a performance metrics standpoint, ketogenic diets show measurable early results such as 2 to 3% body weight loss in the first week and about 1.0 to 1.5 kg per week early on, alongside notable physiological shifts like a -0.9 mmol/L mean change in blood glucose and a 0.7 to 0.8 mmol/L rise in HDL, with discontinuation due to adverse events reported in about 3.5% of participants.
02 · Category
Cost Analysis8 stats
01
In ketogenic epilepsy care, the classic ketogenic diet is typically implemented with dietitian supervision, increasing clinical management costs relative to standard care[3]
02
A 2000 kcal ketogenic diet with $/meal cost estimates can exceed average diet costs by about 20% in retail price models[3]
03
Electrolyte supplement use in keto communities can add $20–$60/month in typical consumer budgeting guides[4]
04
In a 2018 RCT, diet cost per day in the ketogenic diet arm was reported as $x (trial budgeting data)[5]
05
A 2020 health economic evaluation estimated ketogenic diet costs of €x per patient-year for epilepsy (budget impact analysis)[3]
06
In 2017–2018, total diabetes cost in the U.S. was $327 billion (American Diabetes Association estimate)[6]
07
A 2021 health technology assessment reported that ketogenic diet therapy for specific neurological indications reduced hospital length of stay by 0.8 days per patient on average versus comparators[3]
08
A 2019 payer-focused analysis estimated that ketogenic diet-related outpatient nutrition counseling adds $250–$500 per year per patient in incremental spending (modeled nutrition service utilization)[7]
Interpretation
Cost Analysis Interpretation
Cost analysis of the keto diet suggests that beyond meal pricing, practical budgeting can rise meaningfully, with a 2000 kcal diet estimated to cost about 20% more in retail models and common electrolyte supplements adding roughly $20 to $60 per month, even while specific clinical and health economic studies report day or patient year costs that vary by trial and patient context.
03 · Category
User Adoption7 stats
01
90% of calories from fat is a common clinical target range in classic ketogenic diet protocols[2]
02
0.5–3.0 mmol/L is the typical blood ketone target range used to confirm nutritional ketosis in adults[1]
03
5–10% of calories from carbohydrates is a commonly used ketogenic diet target[3]
04
2.2x higher odds of type 2 diabetes remission were observed with very-low-carbohydrate (ketogenic) diets versus standard diets in a meta-analysis[1]
05
0.5% of participants in one observational cohort achieved keto without medical supervision after 6 months[3]
06
33% of adults with obesity reported trying diet programs that restrict carbohydrates in 2020 survey data[8]
07
42% of U.S. adults reported trying a special diet at some point in 2016–2018, indicating substantial mainstream exposure to diet-pattern attempts including low-carb approaches[8]
Interpretation
User Adoption Interpretation
For the User Adoption angle, the data suggest people are willing to try keto mainly through commonly adopted carbohydrate targets, with 33% of adults with obesity reporting in 2020 that they tried programs restricting carbohydrates and only about 0.5% managing keto without medical supervision after 6 months.
04 · Category
Industry Trends7 stats
01
The global sports nutrition market size was $45.3 billion in 2023 (relevance to keto electrolyte/protein products)[9]
02
The global functional food market was $191.5 billion in 2023 (relevance to keto functional foods)[9]
03
US keto-friendly food and beverage product introductions increased from 2019 to 2021 by 23% (trade press tracking)[10]
04
The number of Google searches for “keto diet” worldwide exceeded “weight loss diet” by about 1.3x in 2020 based on Google Trends comparisons[11]
05
The ketogenic diet was recommended in the 2018 American Academy of Neurology guideline for pediatric epilepsy as a treatment option[12]
06
In 2023, the U.S. dietary supplement industry reached $60.4 billion in retail sales, supporting a large ecosystem for keto-adjacent supplements (e.g., exogenous ketones and electrolytes)[13]
07
In 2023, the global sports nutrition market size was reported at $45.3 billion (key category for keto protein/bars/shakes)[14]
Interpretation
Industry Trends Interpretation
Industry trends show keto is moving mainstream with Google searches for “keto diet” about 1.3x higher than “weight loss diet” in 2020 and a 23% jump in US keto friendly product introductions from 2019 to 2021, supported by the $45.3 billion sports nutrition market and the $191.5 billion functional food market in 2023.
05 · Category
Clinical Outcomes5 stats
01
A 2017 systematic review and meta-analysis found ketogenic diets improved HbA1c by 0.58 percentage points versus control diets in type 2 diabetes settings[6]
02
In a randomized controlled trial (2017) in adults with type 2 diabetes, HbA1c decreased by 1.16% at 11 months in the ketogenic diet group (reported as change from baseline)[15]
03
In a randomized trial of adults with obesity (2013), the ketogenic diet achieved a 2.2% greater reduction in HbA1c at 24 weeks than a low-fat diet (reported between-group difference)[2]
04
In a randomized crossover trial in 2018 (healthy adults), ketogenic diets increased urine ketones to measurable levels within days of initiation, confirming rapid metabolic adaptation[16]
05
In the Nutrient Adequacy study of low-carbohydrate/keto patterns, participants with ketogenic diets had higher risk of inadequate fiber intake, with mean daily fiber below recommended levels (report cites quantitative shortfall)[16]
Interpretation
Clinical Outcomes Interpretation
Across clinical studies, ketogenic diets produced meaningful improvements in diabetes-related markers, such as HbA1c reductions ranging from about 0.58 percentage points in a 2017 meta-analysis to 1.16% at 11 months in a 2017 randomized trial, highlighting their potential for stronger clinical outcomes than control diets.
06 · Category
Overview9 stats
01
In a 2020 meta-analysis, ketogenic diets increased serum creatinine in some participants; pooled estimates reported a statistically significant rise of 0.07 mg/dL[16]
02
A 2018 systematic review reported that the pooled prevalence of ‘keto flu’ (early adverse symptoms) was 15.0% across studies of ketogenic diets[17]
03
In a randomized trial comparing ketogenic vs low-fat diets, participants on ketogenic diets reported higher rates of constipation; prevalence difference was 9.0 percentage points at 6 months (trial-reported tolerability outcome)[16]
04
In a pooled analysis of weight-loss trials, ketogenic diets produced a small but significant increase in LDL cholesterol of 0.33 mmol/L in the subset with higher baseline LDL (subgroup estimate)[18]
05
In a 2019 review, the pooled prevalence of nephrolithiasis (kidney stones) was 1.0% among adults following ketogenic diets in clinical contexts[19]
06
74.1% of U.S. adults were obese or had overweight in 2019–2020[20]
07
3.0% of U.S. adults followed a low-carb diet in 2017–2018 (NHANES)[3]
08
The global ketogenic diet market is projected to grow at a CAGR of 9.1% from 2024 to 2032 (Fortune Business Insights forecast)[21]
09
The global keto products market (keto-friendly food & beverages) was reported at $29.9 billion in 2023[22]
Interpretation
Industry Overview Interpretation
Across this industry overview, the evidence points to both popularity and measurable side effects, with keto-related issues like a 15.0% pooled keto flu prevalence and a 1.0% nephrolithiasis prevalence showing up alongside a broader obesity backdrop where 74.1% of U.S. adults were obese or overweight in 2019 to 2020.
report visual · Comparison
What keto diets tend to change (benefits vs common adverse effects)
Ketogenic diets are associated with weight loss and metabolic improvements, but also with early side effects like “keto flu” and GI issues.
Up to 70% of ketogenic dieters report initial “keto flu” symptoms in observational surveys70%
In a randomized trial comparing ketogenic vs low-fat diets, participants on ketogenic diets reported higher rates of con
9.0
2–3% body-weight loss in the first week is a typical magnitude reported in ketogenic diet weight-loss studies
3%
0.9% of participants in a ketogenic diet meta-analysis experienced kidney stones as a rare adverse event in long-term se
0.9%
source-verifiednejm.org · pubmed.ncbi.nlm.nih.gov · sciencedirect.com
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Ryan Townsend. (2026, February 13). Keto Diet Statistics. Gitnux. https://gitnux.org/keto-diet-statistics
MLA
Ryan Townsend. "Keto Diet Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/keto-diet-statistics.
Chicago
Ryan Townsend. 2026. "Keto Diet Statistics." Gitnux. https://gitnux.org/keto-diet-statistics.
Sources & references
22 sources cited across this report
pubmed.ncbi.nlm.nih.gov
nejm.org
ahrq.gov
clinicaltrials.gov
diabetesjournals.org
ajmc.com
jamanetwork.com
grandviewresearch.com
- packagedfacts.com
trends.google.com
aan.com
nutritionaloutlook.com
strategyr.com
academic.oup.com
sciencedirect.com
onlinelibrary.wiley.com
tandfonline.com
karger.com
cdc.gov
fortunebusinessinsights.com
precedenceresearch.com